section name header

Pronunciation

bed- AK-wi-leen audio

Classifications

Therapeutic Classification: antituberculars

Pharmacologic Classification: diarylquinolines

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Absorption following oral administration is doubled by food.

Distribution: Unknown.

Protein Binding: >99.9%.

Metabolism/Excretion: Mostly metabolized (CYP3A4 enzyme system) and eliminated in feces, negligible renal excretion.

Half-life: 5.5 mo (terminal elimination half-life).

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown5 hrunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Neuro: headache.

Resp: hemoptysis.

CV: chest pain, QT interval prolongation.

GI: nausea, anorexia, HEPATOTOXICITY.

Derm: rash.

MS: arthralgia.

Interactions

Drug-Drug:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Sirturo

Code

NDC Code*